In this interview, Dr. Peter McCullough discusses the importance of early treatment for COVID-19, and the potential motivations behind the suppression of safe and effective treatments.
It would be a historically amazing feat of maneuvering bureaucracy, worthy of its own epic book, movie, or perhaps a campfire song, to have wrangled that much data out of those hospitals with highly variable regulations and procedures, nearly all of which are in the U.S. healthcare system.
Source: The Guardian Author: Melissa Davey One of the world’s leading medical journals, the Lancet, has reformed its editorial policies following a shocking case of
NEJM releases papers that don’t differ reactions, lumping them all together so that it makes costly remedies advised by WHO appear to be largely harmless.
“I’ve never seen so many different institutional levels attack, it seems like a coordinated effort to discredit hydroxychloroquine.”
That’s $1.6 billion tax dollars for a virtually untested drug showing only marginal efficacy in the hospital setting.
HCQ Studies are overwhelmingly positive, negative studies get lots of attention but have some serious flaws.
“It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgement of trusted physicians or authoritative medical guidelines.
See the original source: Sunday Guardian Live By Jacob Puliyel Gresham’s law holds that bad money drives out good money. If there are two coins
The Lancet‘s retracted study was based on non-existent data sets furnished by disgraced non-company Surgisphere.
All it took for a safe, generic drug — listed for decades by the World Health Organization (WHO) as one of the drugs that should be immediately and universally available worldwide at all times — to be considered dangerous, was for President Trump to say “I happen to feel good about it.”
The study, which was obviously flawed on its face (I commented well before it was exposed that the groupings made no sense), turned out to be produced by a shell company, with unverified data gathered by non-scientists.
Source: HVMN 13 days after publishing a paper on hydroxychloroquine (a potential drug for coronavirus treatment), The Lancet retracted the study due to faulty data.
Source: The Guardian Questions continue for Surgisphere and CEO Sapan Desai as universities deny knowledge of links to firm behind Lancet’s now-disputed blockbuster study. Dozens
Dr. Anthony Fauci has been deliberately blocking a drug which was endorsed by the CDC 15 years ago for treatment of SARS-1 Coronavirus.
Costa Rica resumed the use of hydroxychloroquine after the medical journal, The Lancet, retracted the results of the study that led the World Health Organization (WHO) suspension of the use of the drug.
Source: The Guardian The World Health Organization and a number of national governments have changed their Covid-19 policies and treatments on the basis of flawed data from
Source: The Lancet Expression of concern: Hydroxychloroquine or chloroquinewith or without a macrolide for treatment of COVID-19:a multinational registry analysis. Important scientific questions have been
Source: Science the Wire If you’re following at all the search for COVID-19 treatments, and possibly even if not, you will have seen the flurry
Source: France Soir Surgisphere is the company responsible for collecting data from Professor Mehra’s study, which has received worldwide attention for the past 7 days. After our first interview
Source: Medicine Uncensored by James M Todaro, MD (Columbia MD, @JamesTodaroMD)May 29, 2020, (updated May 30, 2020) Misinformation is bad. Misinformation in medicine is worse. Misinformation from a
Source: Brasil Sem Medo Study that rejects hydroxychloroquine use in Covid-19 patients is not science, but instrumentalization of science. The twilight of quinine A study
Source: The Guardian Australian researchers query origin of data used for Lancet study. Questions have been raised by Australian infectious disease researchers about a study
Source: El Pais The Medicines Agency considers that the conclusions of the study that alerted about the drug are not “solid enough”. The Spanish Agency
Source: RT360 The Spanish health watchdog has said it sees no reason to stop the use of hydroxychloroquine (HCQ). Several European nations, including France, Italy
Source: RT Russia Russia’s Health Ministry announced it will not ban hydroxychloroquine. The drug has been suspended for use in treating Covid-19 in France, Italy,
Source: Global Research A few years ago the British medical journal, The Lancet, published a paper touting the safety of HCQ. But this was before HCQ
Source: Recovery Trial Professor Peter Horby, Professor Martin LandrayRECOVERY trial Co-chairsNuffield Department of Public HealthOxford24th May 2020 Dear Peter and Martin RECOVERY trial DMC Chairman’s
